Personal Privacy23andMe Sells Rights to Medication Developed Using its Users’ DNAJanuary 14, 2020Personal Privacy23andMeDNAmedicinepharmaceuticals The Infinite BriefDNA testing company 23andMe has sold the rights to a new drug that it has developed using its customers’ data. The deal for the drug, which is being investigated as a potential treatment for inflammatory diseases, is with Spanish pharmaceutical company Almirall. More than 80% of their customers have agreed to their data being used by the company for research and by scientists trying to understand the causes of diseases and how best to treat them. As 23andMe’s genetic database grows – it has doubled in the last couple of years – it will become more likely to yield medically useful information. Curated from New Scientist Tags :23andMeDNAmedicinepharmaceuticalsshare on Facebookshare on Twittershare on LinkedInshare on Redditadd a comment Leave a Response Cancel replyCommentName Email Website Save my name, email, and website in this browser for the next time I comment. US Government-funded Android Phones Given to Low-Income People Include Unremovable MalwareWhatever Happened to Zuckerberg’s Promise of End-to-End Encryption?You Might Also LikePersonal PrivacyA Growing List of Companies Are Now Using Webcams to Monitor Their Remote EmployeesPersonal PrivacyNew Google Data Shows a 350% Increase in Phishing Websites During the Coronavirus PandemicPersonal PrivacyWhat’s the Going Rate for Social Security Numbers on the Dark Web?